Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 13, 2015
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis
Filippo Pietrantonio, Fausto Petrelli, Andrea Coinu, et al.
International Journal of Cancer
|
February 24, 2015
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab
Valeria Musella, Filippo Pietrantonio, Eleonora Di Buduo, et al.
Critical Reviews in Oncology/Hematology
|
May 22, 2019
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives
Claudio Vernieri, Monica Milano, Marta Brambilla, et al.
Plos One
|
April 3, 2014
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status
Filippo Pietrantonio, Claudia Maggi, Maria Di Bartolomeo, et al.
Scientific Reports
|
June 9, 2018
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro, et al.
Medical Oncology (Northwood, London, England)
|
May 25, 2015
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases
Filippo Pietrantonio, Vincenzo Mazzaferro, Rosalba Miceli, et al.
Clinical Breast Cancer
|
January 13, 2019
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles
Claudio Vernieri, Michele Prisciandaro, Monica Milano, et al.
International Journal of Molecular Sciences
|
September 6, 2013
Role of cMET in the development and progression of colorectal cancer
Juan Carlos Samamé Pérez-Vargas, Pamela Biondani, Claudia Maggi, et al.
Italian Journal of Pediatrics
|
July 30, 2022
The COVID-related mental health load of neonatal healthcare professionals: a multicenter study in Italy
Luigi Gagliardi, Serena Grumi, Marzia Gentile, et al.
International Journal of Molecular Sciences
|
April 24, 2015
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase
Felicia Stefania Falvella, Marta Caporale, Stefania Cheli, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
European Journal of Cancer (Oxford, England : 1990)
|
February 13, 2015
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis
Filippo Pietrantonio, Fausto Petrelli, Andrea Coinu, et al.
International Journal of Cancer
|
February 24, 2015
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab
Valeria Musella, Filippo Pietrantonio, Eleonora Di Buduo, et al.
Critical Reviews in Oncology/Hematology
|
May 22, 2019
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives
Claudio Vernieri, Monica Milano, Marta Brambilla, et al.
Plos One
|
April 3, 2014
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status
Filippo Pietrantonio, Claudia Maggi, Maria Di Bartolomeo, et al.
Scientific Reports
|
June 9, 2018
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro, et al.
Medical Oncology (Northwood, London, England)
|
May 25, 2015
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases
Filippo Pietrantonio, Vincenzo Mazzaferro, Rosalba Miceli, et al.
Clinical Breast Cancer
|
January 13, 2019
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles
Claudio Vernieri, Michele Prisciandaro, Monica Milano, et al.
International Journal of Molecular Sciences
|
September 6, 2013
Role of cMET in the development and progression of colorectal cancer
Juan Carlos Samamé Pérez-Vargas, Pamela Biondani, Claudia Maggi, et al.
Italian Journal of Pediatrics
|
July 30, 2022
The COVID-related mental health load of neonatal healthcare professionals: a multicenter study in Italy
Luigi Gagliardi, Serena Grumi, Marzia Gentile, et al.
International Journal of Molecular Sciences
|
April 24, 2015
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase
Felicia Stefania Falvella, Marta Caporale, Stefania Cheli, et al.
Page
of 4